Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- J. P. Duic, M.D.
The Long Island Brain Tumor Center at Neurological Surgery, P.C.
Principal Investigator - Jian Campian, M.D.
Washington University School of Medicine
Principal Investigator - Louis B. Nabors, III, M.D.
University of Alabama at Birmingham
Principal Investigator - Nimish Mohile, M.D.
University of Rochester
Principal Investigator - Pierre Giglio, M.D.
Ohio State University
Principal Investigator - Samuel A. Goldlust, M.D.
John Theurer Cancer Center at Hackensack University Medical Center
Principal Investigator - Sigmund Hsu, M.D.
Memorial Hermann Hospital
Principal Investigator - Tara L. Benkers, M.D.
Swedish Neuroscience Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- John Theurer Cancer Center at Hackensack University Medical Center
Hackensack, New Jersey, United States
- the Long Island Brain Tumor Center at Neurological Surgery, P.C.
Commack, New York, United States
- the Long Island Brain Tumor Center at Neurological Surgery, P.C.
Lake Success, New York, United States
- University of Rochester Medical Center
Rochester, New York, United States
- the Ohio State University Wexner Medical Center
Columbus, Ohio, United States
- Memorial Hermann Hospital
Houston, Texas, United States
- Swedish Neuroscience Institute
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2013
- Primary completion
- 30 Nov 2024
- Completion
- 31 May 2025
- Last update posted
- 22 Feb 2023
- Registered enrollment
- 92
- Registry id
- NCT01933815
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.